Search results
Results From The WOW.Com Content Network
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the Department of Health and Human Services. [1] Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that ...
President Biden and first lady Jill Biden will travel to Louisiana on Tuesday to announce up to $150 million in federal awards for research projects focused on improving cancer surgeries. The ...
It authorizes the DOT to create an organization called the Advanced Research Projects Agency–Infrastructure (ARPA–I), with a broad remit over transportation research akin to DARPA, HSARPA, IARPA, ARPA-E, and ARPA-H, [73] with the first appropriations of $3.22 million being made in the Consolidated Appropriations Act, 2023.
Las Cruces has spent or allocated nearly all of its funding from the COVID-19 era American Rescue Plan Act.
President Joe Biden signs the Consolidated Appropriations Act of 2023 in St. Croix on December 29, 2022. The Consolidated Appropriations Act, 2023 is a $1.7 trillion omnibus spending bill funding the U.S. federal government for the 2023 fiscal year.
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
The Administration for Strategic Preparedness and Response (ASPR) is an operating agency of the U.S. Public Health Service within the Department of Health and Human Services that focuses on preventing, preparing for, and responding to the adverse health effects of public health emergencies and disasters.
Geoffrey S. F. Ling is a medical doctor who retired from the United States Army as a colonel and was the CEO of On Demand Pharmaceuticals. He served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2014 until 2016. [1]